Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria

Abstract Albuminuria development in hypertensive patients is an indicator of higher cardiovascular (CV) risk and renal damage. Chronic renin-angiotensin system (RAS) suppression facilitates blood pressure control but it does not prevent from albuminuria development. We pursued the identification of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marta Martin-Lorenzo, Laura Gonzalez-Calero, Paula J. Martinez, Montserrat Baldan-Martin, Juan Antonio Lopez, Gema Ruiz-Hurtado, Fernando de la Cuesta, Julián Segura, Jesús Vazquez, Fernando Vivanco, Maria G. Barderas, Luis M. Ruilope, Gloria Alvarez-Llamas
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c547ec8a924c4f04a3bc0f0c8d0c34ad
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c547ec8a924c4f04a3bc0f0c8d0c34ad
record_format dspace
spelling oai:doaj.org-article:c547ec8a924c4f04a3bc0f0c8d0c34ad2021-12-02T11:40:43ZImmune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria10.1038/s41598-017-09042-22045-2322https://doaj.org/article/c547ec8a924c4f04a3bc0f0c8d0c34ad2017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-09042-2https://doaj.org/toc/2045-2322Abstract Albuminuria development in hypertensive patients is an indicator of higher cardiovascular (CV) risk and renal damage. Chronic renin-angiotensin system (RAS) suppression facilitates blood pressure control but it does not prevent from albuminuria development. We pursued the identification of protein indicators in urine behind albuminuria development in hypertensive patients under RAS suppression. Urine was collected from 100 patients classified in three groups according to albuminuria development: (a) patients with persistent normoalbuminuria; (b) patients developing de novo albuminuria; (c) patients with maintained albuminuria. Quantitative analysis was performed in a first discovery cohort by isobaric labeling methodology. Alterations of proteins of interest were confirmed by target mass spectrometry analysis in an independent cohort. A total of 2416 proteins and 1223 functional categories (coordinated protein responses) were identified. Immune response, adhesion of immune and blood cells, and phagocytosis were found significantly altered in patients with albuminuria compared to normoalbuminuric individuals. The complement system C3 increases, while Annexin A1, CD44, S100A8 and S100A9 proteins showed significant diminishment in their urinary levels when albuminuria is present. This study reveals specific links between immune response and controlled hypertension in patients who develop albuminuria, pointing to potential protein targets for novel and future therapeutic interventions.Marta Martin-LorenzoLaura Gonzalez-CaleroPaula J. MartinezMontserrat Baldan-MartinJuan Antonio LopezGema Ruiz-HurtadoFernando de la CuestaJulián SeguraJesús VazquezFernando VivancoMaria G. BarderasLuis M. RuilopeGloria Alvarez-LlamasNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marta Martin-Lorenzo
Laura Gonzalez-Calero
Paula J. Martinez
Montserrat Baldan-Martin
Juan Antonio Lopez
Gema Ruiz-Hurtado
Fernando de la Cuesta
Julián Segura
Jesús Vazquez
Fernando Vivanco
Maria G. Barderas
Luis M. Ruilope
Gloria Alvarez-Llamas
Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria
description Abstract Albuminuria development in hypertensive patients is an indicator of higher cardiovascular (CV) risk and renal damage. Chronic renin-angiotensin system (RAS) suppression facilitates blood pressure control but it does not prevent from albuminuria development. We pursued the identification of protein indicators in urine behind albuminuria development in hypertensive patients under RAS suppression. Urine was collected from 100 patients classified in three groups according to albuminuria development: (a) patients with persistent normoalbuminuria; (b) patients developing de novo albuminuria; (c) patients with maintained albuminuria. Quantitative analysis was performed in a first discovery cohort by isobaric labeling methodology. Alterations of proteins of interest were confirmed by target mass spectrometry analysis in an independent cohort. A total of 2416 proteins and 1223 functional categories (coordinated protein responses) were identified. Immune response, adhesion of immune and blood cells, and phagocytosis were found significantly altered in patients with albuminuria compared to normoalbuminuric individuals. The complement system C3 increases, while Annexin A1, CD44, S100A8 and S100A9 proteins showed significant diminishment in their urinary levels when albuminuria is present. This study reveals specific links between immune response and controlled hypertension in patients who develop albuminuria, pointing to potential protein targets for novel and future therapeutic interventions.
format article
author Marta Martin-Lorenzo
Laura Gonzalez-Calero
Paula J. Martinez
Montserrat Baldan-Martin
Juan Antonio Lopez
Gema Ruiz-Hurtado
Fernando de la Cuesta
Julián Segura
Jesús Vazquez
Fernando Vivanco
Maria G. Barderas
Luis M. Ruilope
Gloria Alvarez-Llamas
author_facet Marta Martin-Lorenzo
Laura Gonzalez-Calero
Paula J. Martinez
Montserrat Baldan-Martin
Juan Antonio Lopez
Gema Ruiz-Hurtado
Fernando de la Cuesta
Julián Segura
Jesús Vazquez
Fernando Vivanco
Maria G. Barderas
Luis M. Ruilope
Gloria Alvarez-Llamas
author_sort Marta Martin-Lorenzo
title Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria
title_short Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria
title_full Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria
title_fullStr Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria
title_full_unstemmed Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria
title_sort immune system deregulation in hypertensive patients chronically ras suppressed developing albuminuria
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/c547ec8a924c4f04a3bc0f0c8d0c34ad
work_keys_str_mv AT martamartinlorenzo immunesystemderegulationinhypertensivepatientschronicallyrassuppresseddevelopingalbuminuria
AT lauragonzalezcalero immunesystemderegulationinhypertensivepatientschronicallyrassuppresseddevelopingalbuminuria
AT paulajmartinez immunesystemderegulationinhypertensivepatientschronicallyrassuppresseddevelopingalbuminuria
AT montserratbaldanmartin immunesystemderegulationinhypertensivepatientschronicallyrassuppresseddevelopingalbuminuria
AT juanantoniolopez immunesystemderegulationinhypertensivepatientschronicallyrassuppresseddevelopingalbuminuria
AT gemaruizhurtado immunesystemderegulationinhypertensivepatientschronicallyrassuppresseddevelopingalbuminuria
AT fernandodelacuesta immunesystemderegulationinhypertensivepatientschronicallyrassuppresseddevelopingalbuminuria
AT juliansegura immunesystemderegulationinhypertensivepatientschronicallyrassuppresseddevelopingalbuminuria
AT jesusvazquez immunesystemderegulationinhypertensivepatientschronicallyrassuppresseddevelopingalbuminuria
AT fernandovivanco immunesystemderegulationinhypertensivepatientschronicallyrassuppresseddevelopingalbuminuria
AT mariagbarderas immunesystemderegulationinhypertensivepatientschronicallyrassuppresseddevelopingalbuminuria
AT luismruilope immunesystemderegulationinhypertensivepatientschronicallyrassuppresseddevelopingalbuminuria
AT gloriaalvarezllamas immunesystemderegulationinhypertensivepatientschronicallyrassuppresseddevelopingalbuminuria
_version_ 1718395604586987520